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J-Shaped Relation Between Blood Pressure and Stroke in
Treated Hypertensives
Zolta´n Voko´, Michiel L. Bots, Albert Hofman, Peter J. Koudstaal,
Jacqueline C.M. Witteman, Monique M.B. Breteler
Abstract—The objective of this study was to investigate the relationship between hypertension and risk of stroke in the
elderly. The study was performed within the framework of the Rotterdam Study, a prospective population-based cohort
study. The risk of first-ever stroke was associated with hypertension (relative risk, 1.6; 95% CI, 1.2 to 2.0) and with
isolated systolic hypertension (relative risk, 1.7; 95% CI, 1.1 to 2.6). We found a continuous increase in stroke incidence
with increasing blood pressure in nontreated subjects. In treated subjects, we found a J-shaped relation between blood
pressure and the risk of stroke. In the lowest category of diastolic blood pressure, the increase of stroke risk was
statistically significant compared with the reference category. Hypertension and isolated systolic hypertension are strong
risk factors for stroke in the elderly. The increased stroke risk in the lowest stratum of blood pressure in treated
hypertensive patients may indicate that the therapeutic goal of “the lower the better” is not the optimal strategy in
the elderly. (Hypertension. 1999;34:1181-1185.)
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Hypertension is a well-established risk factor for stroke inelderly people.1–6 There is increasing evidence showing
the importance of isolated systolic hypertension in the etiol-
ogy of stroke,1,7–13 and now it is recognized as an independent
risk factor for cardiovascular morbidity and mortality.14–16
The results of clinical trials indicated that treatment of
hypertension could reduce the risk of stroke considerably, in
the elderly as well.17–21 Although 2 clinical trials have
investigated the optimal target blood pressure level in treated
hypertensive patients, it is still a question whether the risk of
stroke continues to decrease the further blood pressure is
reduced in hypertensive patients.22–24
We performed a prospective cohort study in an elderly
Dutch population to investigate the relationship between
hypertension and stroke in the elderly. Furthermore, we
studied the relationship between blood pressure level and the
risk of stroke separately in subjects using and not using
antihypertensive medication.
Methods
Study Population
This study was conducted within the framework of the Rotterdam
Study, an ongoing prospective population-based cohort study for
which all inhabitants aged 55 years or over, living in the suburb of
Rotterdam, the Netherlands, were invited. The rationale and design
of the Rotterdam Study have been described elsewhere.25
Baseline data collection was performed between 1990 and 1993.
Written informed consent and permission to retrieve information
from medical records were obtained from every participant. The
study has been approved by the Medical Ethics Committee of the
University Hospital of Rotterdam. In total, 7983 subjects participated
(response rate, 78%). Among them, 7725 subjects reported no
previous stroke at baseline, and of them, 6927 visited the research
center, where their blood pressure was measured. Among them, the
distribution of age and gender and the frequency of diabetes, angina,
and previous myocardial infarction were similar to the rest of the
cohort.
Outcome
Once subjects enter the study, they are continuously monitored and
followed through linkage with automated medical records of the
general practitioners working in the study area. Furthermore, bi-
monthly updates from the municipality records are obtained. When
an event or death is reported, additional information is obtained by
interviewing the general practitioner and scrutinizing the medical
files or hospital discharge records in case of admittance or referral.
This analysis concerns events that occurred until December 31, 1996.
Complete follow-up was available for 6287 subjects (91%).
All suspected stroke cases reported were reviewed by a neurolo-
gist (P.J.K.), who classified them as definite, probable, or possible
strokes or as nonstroke events26 and determined stroke subtypes.
Determinants
Sitting blood pressure was measured at baseline in the right upper
arm with a random-zero sphygmomanometer. The average of 2
measurements obtained on 1 occasion, separated by a count of the
pulse rate, was used in this analysis.27 Use of medication was
ascertained as part of the baseline interview in the subject’s home.
Hypertension was defined as systolic blood pressure $160 mm Hg,
diastolic blood pressure $95 mm Hg, or use of antihypertensive
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medication.27 Isolated systolic hypertension was defined as systolic
blood pressure $160 mm Hg, diastolic blood pressure ,90 mm Hg,
and no treatment for hypertension.
Potential Confounders
With respect to smoking behavior, subjects were categorized as
current or former smokers and those who never smoked. Diabetes
mellitus was defined as random or postload serum glucose
.11.1 mmol/L or use of antidiabetic medication.28 Prevalence of
angina pectoris and claudication was assessed by means of a Dutch
version of the cardiovascular questionnaire of Rose et al.29 Ankle-
to-arm systolic blood pressure index was defined as the ratio of the
systolic blood pressure measured at the arm and at the ankle at the
same side.30 A history of transient ischemic attack (TIA) was
assessed on the basis of answers to the questions about experiencing
a short period with disturbances of sensibility, strength, speech, or
vision. If a positive answer was given, more detailed information was
obtained, and the event was categorized as typical TIA, atypical, or
no TIA by a neurologist (P.J.K.).31 History of stroke or myocardial
infarction was assessed primarily by direct questioning. Self-
reported events were confirmed by additional information from the
general practitioner, cardiologist, or neurologist.32,33
Statistical Analysis
All first-ever strokes were included in the analysis. Relative risks and
95% CIs were estimated through Cox regression.
We compared the risk of stroke between hypertensive and normo-
tensive subjects and between subjects with isolated systolic hyper-
tension and nontreated subjects having systolic blood pressure
,160 mm Hg and diastolic blood pressure ,90 mm Hg. The risk
estimates were adjusted for age, gender, smoking habits, and
diabetes mellitus. We refrained from adjustment for cardiovascular
diseases because they were considered intermediate steps in the
disease process or indicators of severe hypertension.
We also investigated the effect of blood pressure level on stroke
risk among treated and nontreated subjects. To reduce confounding
caused by severe atherosclerosis associated with high systolic and
low diastolic blood pressure, these analyses were adjusted for age,
gender, smoking habits, diabetes mellitus, ankle-to-arm index, minor
vascular events (intermittent claudication, angina pectoris, history of
coronary revascularization procedure), myocardial infarction, atrial
fibrillation, and typical and atypical TIA.
Missing data of potential confounders were handled by the
indicator method.34 On all confounders, .90% of data were
available.
Results
Table 1 shows the baseline characteristics of the study
population. The study cohort was followed for an average of
4.7 years. Among them, 277 first-ever strokes occurred. Of
these strokes, 7.2% were hemorrhagic, 73.7% were ischemic,
and 19.1% could not be specified.
A statistically significant association between hyperten-
sion, isolated systolic hypertension, and the risk of first-ever
stroke was observed (Table 2).
In subjects who did not use antihypertensive medication, a
continuous increase in risk was observed with increasing
level of both systolic (Figure 1) and diastolic (Figure 2) blood
pressure. In patients who used antihypertensive drugs, a
J-shaped relation was found between both systolic and
diastolic blood pressure and the incidence of stroke. For
diastolic blood pressure, the increase of the risk in the lowest
category compared with the reference was statistically
significant.
To examine the possibility that the J-curve that we found
was due to the excess number of subjects with isolated
systolic hypertension among those with the lowest diastolic
blood pressure, we excluded subjects with isolated systolic
hypertension. This did not materially change our results. We
performed analyses with adjustment for systolic blood pres-
sure and also with exclusion of subjects with history of
myocardial infarction or coronary revascularization proce-
dure. This did not change the shape of the relationship
between diastolic blood pressure and stroke.
TABLE 1. Baseline Characteristics of the Study Population
Characteristic
Hypertensive
Subjects
(n52351)
Normotensive
Subjects
(n53936)
Age, y 71.5 (8.9) 68.4 (8.9)
Systolic blood pressure, mm Hg 156.7 (22.4) 130.5 (16.1)
Diastolic blood pressure, mm Hg 79.9 (12.4) 70.4 (9.8)
Serum cholesterol, mmol/L 6.7 (1.2) 6.6 (1.2)
Men 34.3 42.4
Current smoker 18.4 25.2
Former smoker 40.4 41.9
Diabetes mellitus 16.4 7.7
Atrial fibrillation 3.2 2.4
Intermittent claudication 2.3 1.2
Angina pectoris 9.7 5.3
Coronary revascularization 3.8 2.6
History of myocardial infarction 16.1 10.8
History of typical TIA 1.9 1.3
History of atypical TIA 2.5 1.4
Values are mean (SD) or percentage.
TABLE 2. Association Between Hypertension, Isolated Systolic Hypertension, and Risk of First-Ever Stroke
Determinant
Persons
at Risk
Number of
Strokes
Strokes/1000
Person-Years
Relative Risk (95% CI)
Adjusted for Age
and Gender
Additional
Adjustment*
Hypertension
No 3936 130 7.0 1.00 (reference) 1.00 (reference)
Yes 2351 147 13.8 1.59 (1.25–2.02) 1.58 (1.24–2.01)
Isolated systolic hypertension
No 3241 92 5.9 1.00 (reference) 1.00 (reference)
Yes 345 25 15.8 1.80 (1.15–2.81) 1.69 (1.08–2.64)
*Adjusted for smoking habit and diabetes mellitus.
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Discussion
We found associations of hypertension and isolated systolic
hypertension with the occurrence of stroke. This is the first
study clearly showing a J-shaped relation between diastolic
blood pressure and the incidence of stroke in treated hyper-
tensive subjects.
Regarding the relation between hypertension, isolated sys-
tolic hypertension, and risk of stroke in the elderly, our results
are in accordance with the results of other epidemiological
studies.1–13
However, we may have slightly underestimated the risk of
stroke in hypertensive subjects, since some subjects could
have started taking antihypertensive medication after baseline
and this could have decreased their risk. Nevertheless, we
think that this has not greatly influenced our major findings.
Most of the studies published on the association of blood
pressure and the risk of stroke indicate a continuous increase
in risk over the whole range of blood pressure,35 although few
could evaluate the relationship between blood pressure and
stroke risk in elderly subjects with very low blood pressure.36
Nonetheless, in a case-control study an increased risk of
stroke was reported in treated hypertensive patients with low
diastolic or systolic blood pressure.37 In the Cardiovascular
Health Study, a cohort study similar to the Rotterdam Study,
the risk of stroke tended to increase in treated hypertensive
patients whose systolic blood pressure was ,128 mm Hg.6 In
a cohort of Norwegian elderly subjects, an increase of stroke
mortality was seen at low diastolic blood pressure.38 Al-
though none of these results were statistically significant,
they are in accord with our findings, and they suggest that the
optimal target level of blood pressure in elderly hypertensive
patients might be higher than the conventional “normal”
level. Similar results have been repeatedly reported on the
relation between blood pressure and myocardial infarc-
tion.39,40 In this case, however, the relationship does not seem
to be restricted to treated subjects.41–44
Two intervention trials have addressed the question of
optimal blood pressure reduction. In the Behandla Blodtryck
Battre trial, there was no difference in cardiovascular mortal-
ity and morbidity between subjects with essential hyperten-
sion who had their diastolic blood pressure lowered to
,80 mm Hg or to between 90 and 100 mm Hg. However,
only few cases of strokes and myocardial infarctions occurred
during the follow-up, and thus the power of this study is
limited.22 The Hypertension Optimal Treatment trial investi-
gated the relation between 3 levels of target diastolic blood
pressure (#90, #85, or 80 mm Hg) and the incidence of
cardiovascular morbidity and mortality in hypertensive pa-
tients. For stroke, the lowest risk was in the group with
diastolic blood pressure ,80 mm Hg and an average systolic
blood pressure of 142.2 mm Hg. However, the study did not
have enough power to study the relationship at ,130 mm Hg
systolic blood pressure and ,75 mm Hg diastolic blood
pressure, and therefore it neither confirmed nor excluded the
possibility of a J-shaped relation.24
One explanation for the J curve could be that the progres-
sion of atherosclerosis causes a wide pulse pressure through
vessel wall stiffening accompanied by low diastolic pressure,
Figure 1. Association between systolic
blood pressure and risk of first-ever
stroke, according to antihypertensive
treatment. Reference category is the
second lowest category of systolic blood
pressure. Values are plotted on logarith-
mic scale. *Adjusted for age, gender,
smoking habit, diabetes mellitus, ankle-
to-arm index, minor vascular events
(intermittent claudication, angina pecto-
ris, history of coronary revascularization
procedure), myocardial infarction, atrial
fibrillation, and typical and atypical TIA.
Figure 2. Association between diastolic
blood pressure and risk of first-ever
stroke, according to antihypertensive
treatment. Reference category is the
second lowest category of diastolic
blood pressure. Values are plotted on
logarithmic scale. *Adjusted for age, gen-
der, smoking habit, diabetes mellitus,
ankle-to-arm index, minor vascular
events (intermittent claudication, angina
pectoris, history of coronary revascular-
ization procedure), myocardial infarction,
atrial fibrillation, and typical and atypical
TIA.
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and that is why low diastolic blood pressure is associated with
excess cardiovascular morbidity.45–47 Our data suggest that
advanced atherosclerosis cannot explain or can only partly
explain the phenomenon, since we found the J-shaped rela-
tionship after adjustment for major cardiovascular risk factors
and cardiovascular diseases and after exclusion of subjects
with myocardial infarction and coronary revascularization
procedure.
An excess number of subjects having isolated systolic
hypertension among those with the lowest diastolic blood
pressure could be another plausible explanation for the J
curve we found. However, this was not the case in our study.
The relationship between diastolic blood pressure and stroke
remained essentially the same after adjustment for systolic
blood pressure or exclusion of subjects with isolated systolic
hypertension.
It is likely that another mechanism can play a role in the
increased stroke risk among treated hypertensive subjects
with very low blood pressure also. Chronic hypertension
shifts the lower and upper blood pressure limits of cerebral
blood flow autoregulation toward higher pressure.48 This
adaptive change protects the brain against high intravascular
pressure, but at the same time it makes the brain more
susceptible to ischemia at low blood pressure. In elderly
subjects this change may be irreversible.49
Within the group of treated subjects, we could not inves-
tigate to what extent low blood pressure was due to the
antihypertensive treatment itself. Nevertheless, low blood
pressure did not increase the risk of stroke in nontreated
subjects.
The risk of stroke in elderly hypertensives seems lowest at
blood pressure levels of '140/80 mm Hg. In view of current
evidence, cautious reduction of blood pressure in elderly
individuals is recommended.
Acknowledgments
The Rotterdam Study was supported by the NESTOR stimulation
program for geriatric research in the Netherlands (Ministry of Health
and Ministry of Education), the Netherlands Organization for Sci-
entific Research (NWO), the Netherlands Prevention Fund, and the
municipality of Rotterdam. Dr Voko´ was supported by the Ministry
of Health of Hungary and by NIHES, Erasmus University, Rotter-
dam, Netherlands. Dr Bots was supported by the Netherlands Heart
Foundation (grant 96.141). Dr Breteler is a fellow of the Royal
Netherlands Academy of Arts and Sciences. We are grateful to the
participants, general practitioners, and field workers in the
Rotterdam Study.
References
1. Shekelle RB, Ostfeld AM, Klawans HL. Hypertension and risk of stroke
in an elderly population. Stroke. 1974;5:71–75.
2. Davis PH, Dambrosia JM, Schoenberg BS, Schoenberg DG, Pritchard
DA, Lilienfeld AM, Whisnant JP. Risk factors for ischemic stroke: a
prospective study in Rochester, Minnesota. Ann Neurol. 1987;22:
319–327.
3. Evans JG. Blood pressure and stroke in an elderly English population. J
Epidemiol Community Health. 1987;41:275–282.
4. Vokonas PS, Kannel WB, Cupples LA. Epidemiology and risk of hyper-
tension in the elderly: the Framingham Study. J Hypertens. 1988;6(suppl
1):S3–S9.
5. Guzik HJ, Ooi WL, Frishman WH, Greenberg S, Aronson MK. Hyper-
tension: cardiovascular implications in a cohort of old old. J Am Geriatr
Soc. 1992;40:348–353.
6. Manolio TA, Kronmal RA, Burke GL, O’Leary DH, Price TR, for the
CHS Collaborative Research Group. Short-term predictors of incident
stroke in adults. Stroke. 1996;27:1479–1486.
7. Kannel WB, Wolf PA, McGee DL, Dawber TR, McNAmara P, Castelli
WP. Systolic blood pressure, arterial rigidity, and risk of stroke: the
Framingham Study. JAMA. 1981;245:1225–1229.
8. Forette F, de la Fuentex, Goldmard JL, Henry JF, Hervy MP. The
prognostic significance of isolated systolic hypertension in the elderly:
results of a ten year longitudinal survey. Clin Exp Hypertens. 1982;4:
1177–1191.
9. Garland C, Barreth-Connor E, Suarez L, Criqui MH. Isolated systolic
hypertension and mortality after age 60 years: a prospective
population-based study. Am J Epidemiol. 1983;118:365–376.
10. Rutan GH, Kuller LH, Neaton JD, Wentworth DH, McDonald RH,
McFate Smith W. Mortality associated with diastolic hypertension and
isolated hypertension among men screened for the Multiple Risk Factor
Intervention Trial. Circulation. 1988;77:504–514.
11. Petropvich H, Curb D, Bloom-Marcus E. Isolated systolic hypertension
and risk of stroke in Japanese-American men. Stroke. 1995;26:25–29.
12. Nielsen WB, Vestbo J, Jensen GB. Isolated systolic hypertension as a
major risk factor for stroke and myocardial infarction and an unexploited
source of cardiovascular prevention: a prospective population-based
study. J Hum Hypertens. 1995;9:175–180.
13. O’Donell CJ, Ridker PM, Glynn RJ, Berger K, Ajani U, Manson JE,
Hennekens CH. Hypertension and borderline isolated systolic hyper-
tension increase risks of cardiovascular disease and mortality in male
physicians. Circulation. 1997;95:1132–1137.
14. The Working Group on Hypertension in the Elderly. Statement on hyper-
tension in the elderly. JAMA. 1986;256:70–74.
15. Borhani NO. Isolated systolic hypertension in the elderly. J Hypertens.
1988;6(suppl 1):S15–S19.
16. Silagy CA, McNeil JJ. Epidemiologic aspects of isolated systolic hyper-
tension and implications for future research. Am J Cardiol. 1992;69:
213–218.
17. Coope J, Warrender TS. Randomised trial of treatment of hypertension in
elderly patients in primary care. BMJ. 1986;293:1145–1151.
18. Dahlo¨f B, Lindholm LH, Hansson L, Scherste´n B, Ekbom T, Wester P-O.
Morbidity and mortality in the Swedish Trial in Old Patients With
Hypertension (STOP-Hypertension). Lancet. 1991;338:1281–1285.
19. SHEP Cooperative Research Group. Prevention of stroke by antihyper-
tensive drug treatment in old persons with isolated systolic hypertension.
JAMA. 1991;265:3255–3264.
20. MRC Working Party. Medical Research Council trial of treatment of
hypertension in older adults: principal results. BMJ. 1992;304:405–412.
21. Staessen JA, Fagard R, Thijs L, Celis H, Arbidze GG, Birkenhager WH,
Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti
G, Nachev C, O’Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J,
Zanchetti A, for the Systolic Hypertension in Europe (Syst-Eur) Trial
Investigators. Randomised double-blind comparison of placebo and
active treatment for older patients with isolated systolic hypertension.
Lancet. 1997;350:757–764.
22. Hansson L. The BBB Study: the effect of intensified antihypertensive
treatment on the level of blood pressure, side effects, morbidity and
mortality in “well-treated” hypertensive patients: Behandla Blodtryck
Battre. Blood Press. 1994;3:248–254.
23. Hansson L, Zanchetti A, Carruthers SG, Dahlo¨f B, Elmfeldt D, Julius S,
Me´nard J, Rahn KH, Wedel H, Westerling S, for the HOT Study Group.
Effects of intensive blood-pressure lowering and low-dose aspirin in
patients with hypertension: principal results of the Hypertension Optimal
Treatment (HOT) randomised trial. Lancet. 1998;351:1755–1762.
24. Kaplan N. J-curve not burned off by HOT study. Lancet. 1998;351:
1748–1749.
25. Hofman A, Grobbee DE, DeJong PTVM, van den Ouweland FA. Deter-
minants of disease and disability in the elderly: the Rotterdam Elderly
Study. Eur J Epidemiol. 1991;7:403–422.
26. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common
carotid intima-media thickness and risk of stroke and myocardial
infarction: the Rotterdam Study. Circulation. 1997;96:1432–1437.
27. 1988 Joint National Committee. The report of the Joint National Com-
mittee on detection, evaluation, and treatment of high blood pressure.
Arch Intern Med. 1988;148:1023–1038.
28. Stolk RP, Pols HAP, Lamberts SWJ, de Jong PTVM, Hofman A, Grobbee
DE. Diabetes mellitus, impaired glucose tolerance, and hyperinsulinaemia
in an elderly population: the Rotterdam Study. Am J Epidemiol. 1997;
145:24–32.
1184 Hypertension December 1999
29. Rose GA, Blackburn H, Gillum RF, Prineas RL. Cardiovascular Survey
Methods. Geneva, Switzerland: World Health Organization; 1982.
30. Bots ML, Hofman A, Grobbee DE. Common carotid intima-media
thickness and lower extremity arterial atherosclerosis: the Rotterdam
Study. Arterioscler Thromb. 1994;14:1885–1891.
31. Bots ML, van der Wilk EC, Koudstaal PJ, Hofman A, Grobbee DE.
Transient neurological attacks in the general population: prevalence, risk
factors, and clinical relevance. Stroke. 1997;28:768–773.
32. de Bruyne MC, Mosterd A, Hoes AW, Kors JA, Kruijssen DACM, van
Bemmel JH, Hofman A, Grobbee DE. Prevalence, determinants and
misclassification of myocardial infarction in the elderly: the Rotterdam
Study. Epidemiology. 1997;8:495–500.
33. Bots ML, Looman SJ, Koudstaal PJK, Hofman A, Hoes AW, Grobbee
DE. Prevalence of stroke in the general population: the Rotterdam Study.
Stroke. 1996;27:1499–1501.
34. Miettinen OS. Theoretical Epidemiology. New York, NY: John Wiley &
Sons, Inc; 1985:231–233.
35. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R,
Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart
disease, part 1: prolonged differences in blood pressure: prospective
observational studies corrected for regression dilution bias. Lancet. 1990;
335:765–774.
36. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment
and the risks of stroke and coronary heart disease. Br Med Bull. 1994;
50:272–278.
37. Al-Roomi KA, Heller RF, Wlodarczyk J. Hypertension control and the
risk of myocardial infarction and stroke: a population-based study. Med J
Aust. 1990;153:595–603.
38. Selmer R. Blood pressure and twenty-year mortality in the city of Bergen,
Norway. Am J Epidemiol. 1992;136:428–440.
39. Cruickshank JM. Coronary flow reserve and the J curve relation between
diastolic blood pressure and myocardial infarction. BMJ. 1988;297:
1227–1230.
40. Merlo J, Ranstam J, Liedholm H, Hedblad B, Liendberg G, Lindblad U,
Isacsson SO, Melander A, Rastam L. Incidence of myocardial infarction
in elderly men being treated with antihypertensive drugs: population
based cohort study. BMJ. 1996;313:457–461.
41. D’Agostino RB, Belanger AJ, Kannel WB, Cruickshank JM. Relation of
low diastolic blood pressure to coronary heart disease death in presence
of myocardial infarction: the Framingham Study. BMJ. 1991;303:
385–389.
42. Staessen J, Bulpitt C, Clement D, De Leeuw P, Fagard R, Fletcher A,
Forette F, Leonetti G, Nissinen A, O’Malley K, Tuomilehto J, Webster
J, Williams BO. Relation between mortality and treated blood pressure
in elderly patients with hypertension: report of the European Working
Party on High Blood Pressure in the Elderly. BMJ. 1989;298:
1552–1556.
43. Coope J. Hypertension: the cause of the J-curve. J Hum Hypertens.
1990;4:1–4.
44. Flechter AK, Bulpitt CJ. How far should blood pressure be lowered?
N Engl J Med. 1992;326:251–254.
45. Sleight P. Blood pressure, hearts, and U-shaped curves. Lancet. 1988;
1:235. Letter.
46. Witteman JCM, Grobbee DE, Valkenburg HA, van Hemert AM, Stijnen
T, Burger H, Hofman A. J-shaped relation between change in diastolic
blood pressure and progression of aortic atherosclerosis. Lancet. 1994;
343:504–507.
47. Bots ML, Witteman JCM, Hofman A, de Jong PTVM, Grobbee DE. Low
diastolic blood pressure and atherosclerosis in the elderly: the Rotterdam
Study. Arch Intern Med. 1996;156:843–848.
48. Strandgaard S, Paulson OB. Cerebral blood flow and its pathophysiology
in hypertension. Am J Hypertens. 1989;2:486–492.
49. Strandgaard S. Cerebral blood flow in the elderly: impact of hypertension
and antihypertensive treatment. Cardiovasc Drugs Ther. 1991;(suppl
6):1217–1221.
Voko´ et al Blood Pressure and Stroke: The Rotterdam Study 1185
